These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3671896)

  • 1. Nifedipine attenuates acute hypoxic pulmonary vasoconstriction in patients with chronic obstructive pulmonary disease.
    Burghuber OC
    Respiration; 1987; 52(2):86-93. PubMed ID: 3671896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with chronic obstructive pulmonary disease. A controlled double-blind study.
    Kennedy TP; Michael JR; Huang CK; Kallman CH; Zahka K; Schlott W; Summer W
    Am Rev Respir Dis; 1984 Apr; 129(4):544-51. PubMed ID: 6711997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension.
    Young TE; Lundquist LJ; Chesler E; Weir EK
    Am J Cardiol; 1983 Jan; 51(1):195-200. PubMed ID: 6571766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and long term effect of nifedipine on pulmonary hypertension secondary to chronic obstructive airways disease.
    Johnson DC; Joshi RC; Mehta R; Cunnington AR
    Eur J Respir Dis Suppl; 1986; 146():495-502. PubMed ID: 3465575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifedipine reduces pulmonary pressure and vascular tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease.
    Agostoni P; Doria E; Galli C; Tamborini G; Guazzi MD
    Am Rev Respir Dis; 1989 Jan; 139(1):120-5. PubMed ID: 2912331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine attenuates acute hypoxic pulmonary vasoconstriction in awake piglets.
    Redding GJ; Tuck R; Escourrou P
    Am Rev Respir Dis; 1984 May; 129(5):785-9. PubMed ID: 6721276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of oxygen, nifedipine and ketanserin in hypoxic pulmonary hypertension.
    Hamet A; Král B; Cernohorský D
    Cor Vasa; 1985; 27(6):406-11. PubMed ID: 2936568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of nifedipine on secondary pulmonary hypertension in man.
    Garzaniti N; el Allaf D; D'Orio V; Cremers S; Marcelle R; Carlier J
    Acta Cardiol; 1985; 40(2):207-15. PubMed ID: 3873156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Variable hemodynamic response to nifedipine in pulmonary hypertension secondary to chronic obstructive bronchopathy and pulmonary fibrosis].
    Domenighetti G
    Schweiz Med Wochenschr; 1985 Sep; 115(39):1345-7. PubMed ID: 4071009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of captopril on hemodynamics and blood gases in chronic obstructive lung disease with pulmonary hypertension.
    Bertoli L; Lo Cicero S; Busnardo I; Rizzato G; Montanari G
    Respiration; 1986; 49(4):251-6. PubMed ID: 3520734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine.
    Kennedy T; Summer W
    Am J Cardiol; 1982 Oct; 50(4):864-8. PubMed ID: 7124646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease.
    Packer M; Medina N; Yushak M
    J Am Coll Cardiol; 1984 Nov; 4(5):890-901. PubMed ID: 6491082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nifedipine on physiologic shunting and oxygenation in chronic obstructive pulmonary disease.
    Kalra L; Bone MF
    Am J Med; 1993 Apr; 94(4):419-23. PubMed ID: 8475936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vasodilator therapy in pulmonary hypertension and chronic obstructive lung disease (COPD). Hemodynamic studies exemplified by nifedipine and nitroglycerin].
    Gassner A; Fridrich L; Magometschnigg D; Sommer G; Klicpera M
    Herz; 1986 Aug; 11(4):207-16. PubMed ID: 3093345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone: effects on hypoxic pulmonary vasoconstriction.
    Bar-Or D; Good JT; Marx JA; Moore EE; Winkler JV
    Ann Emerg Med; 1984 Jul; 13(7):495-8. PubMed ID: 6331231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nifedipine on pulmonary arterial hypertension in patients with respiratory insufficiency without acute failure.
    Gaucher LR; Payen DM; Minsart PJ; Peltier PM; Ordronneau JJ; Grolleau JY
    Respiration; 1984; 45(4):443-9. PubMed ID: 6433415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic application of calcium-channel antagonists for pulmonary hypertension.
    Packer M
    Am J Cardiol; 1985 Jan; 55(3):196B-201B. PubMed ID: 3881914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of minoxidil and nifedipine on hypoxic pulmonary vasoconstriction in dogs.
    Bishop MJ; Cheney FW
    J Cardiovasc Pharmacol; 1983; 5(2):184-9. PubMed ID: 6188887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension.
    Brownlee JR; Beekman RH; Rosenthal A
    Pediatr Res; 1988 Aug; 24(2):186-90. PubMed ID: 3186330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of inhaled nitric oxide on the pulmonary circulation of the neonatal pig.
    Nelin LD; Moshin J; Thomas CJ; Sasidharan P; Dawson CA
    Pediatr Res; 1994 Jan; 35(1):20-4. PubMed ID: 8134193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.